Procyon Advisors, LLC Veracyte, Inc. Transaction History
Procyon Advisors, LLC
- $1.44 Billion
- Q3 2024
A detailed history of Procyon Advisors, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Procyon Advisors, LLC holds 10,981 shares of VCYT stock, worth $477,783. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,981
Previous 15,087
27.22%
Holding current value
$477,783
Previous $326,000
14.42%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding VCYT
# of Institutions
308Shares Held
81.8MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$339 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$337 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$219 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$214 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$184 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.11B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...